摘要
目的:探讨16岁以下儿童使用注射用阿奇霉素(AZ)的安全性。方法:通过文献检索出有关小儿AZ静脉用药的相关文献及16岁以下儿童使用该药引起ADR的报道,对符合条件的文献按疾病种类、病例数、性别、年龄、剂量、ADR症状及发生时间等进行统计分析。结果:共检索到各类"临床应用"220篇,"个案报道"29篇。文献分布于全国34个省、市。注射用AZ治疗呼吸道细菌、肺炎支原体及恙虫病等感染的有效率均在90以上。不良反应发生率为12.41,主要有消化系统反应、过敏反应和注射部位疼痛,还有引起其它反应的报道。结论:注射用AZ儿童使用较为安全。
Objective:To approach the azithromycin injection-induced adverse reaction and safety in treatment of patients below 16 years. Methods :Through literature retrieval, azithromycin injection-induced ADRs cases below 16 years reported through internet were collected and analyzed statistically. Results:220 literatures on clinical applications and 29 case reports of azithromycin injections were collected, which were distributed in every province in the country. A total effective rate was obtained more than 90% but for the cases of respiratory infection there was an incidence of 12.41% of mild adverse reaction. The ADRs of azithromycin injection had various manifestations :mostly allergic reactions, digestive system, injection site ache and others. Conclusions:The result suggests that injectable azithmmycin is effective in treatment of children but with mild adverse reaction.
出处
《儿科药学杂志》
CAS
2008年第6期9-12,共4页
Journal of Pediatric Pharmacy
关键词
阿奇霉素
儿童
不良反应
安全性
Azithmmycin
Children
Adverse reaction
Safety